← back to search

Andrea Krämer

Illinois Bone and Joint Institute ·
🔎 Find collaborators in Cell Biology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cell Biology · Oncology
Research interest
Research interests include Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways, and HIV-related health complications and treatments.
h-index
24
citations
2,920
works
49
NIH funding
primary concept
email

Recent publications

Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors
Cancers 2023cited by 4position: middledoi
Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer
Cellular and Molecular Life Sciences 2023cited by 2position: middledoi
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer
Cellular and Molecular Life Sciences 2022cited by 10position: middledoi
Boosting the apoptotic response of high‐grade serous ovarian cancers with <i>CCNE1</i> amplification to paclitaxel <i>in vitro</i> by targeting APC/C and the pro‐survival protein MCL‐1
International Journal of Cancer 2019cited by 24position: middledoi
Synthetic lethality in <i>CCNE1</i>-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics
Oncotarget 2018cited by 33position: middledoi
Karyotype complexity and prognosis in acute myeloid leukemia
Blood Cancer Journal 2016cited by 107position: middledoi
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Nature 2015cited by 604position: middledoi
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia
Leukemia 2015cited by 24position: middledoi
Mitotic arrest and slippage induced by pharmacological inhibition of Polo‐like kinase 1
Molecular Oncology 2014cited by 54position: middledoi
Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells
Cell Research 2014cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Klaus Strebhardt · Goethe University Frankfurt7 papers (2014–2023)Sven Becker · Goethe University Frankfurt6 papers (2014–2023)Mourad Sanhaji · Indiana University School of Medicine6 papers (2014–2023)Monika Raab · University Hospital Frankfurt4 papers (2019–2023)Khayal Gasimli · Charité - Universitätsmedizin Berlin3 papers (2022–2023)Samuel Peña‐Llopis · Essen University Hospital3 papers (2022–2023)Ranadip Mandal · Goethe University Frankfurt3 papers (2022–2023)Elisabeth Kurunci‐Csacsko · University Hospital Frankfurt3 papers (2014–2019)Monika Raab · Goethe University Frankfurt3 papers (2014–2018)Izabela Kostova · University Hospital Frankfurt2 papers (2022–2023)Thomas Oellerich · Goethe University Frankfurt2 papers (2022–2023)Franz Rödel · German Cancer Society2 papers (2022–2023)Fiona Pachl · Technical University of Munich2 papers (2014–2014)Bernhard Küster · German Cancer Research Center2 papers (2014–2014)Björn Häupl · Goethe University Frankfurt2 papers (2022–2023)Gioele Medici · University of Zurich2 papers (2022–2023)Jürgen G. Okun · Heidelberg University1 papers (2015–2015) · 1 papers (2014–2014)Yves Matthess · Goethe University Frankfurt1 papers (2018–2018)Christian Thiede · TiGenix (Spain)1 papers (2015–2015)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cell Biology · Oncology →